Comparison of Donepezil and Riluzole in Improving Spatial Memory of Male Wistar Rats

Sina Andalib; Mojtaba Ziaee; Faezeh Mozafari; Reza Hosseini; Mahdieh Anoush

doi:10.4103/jrptps.JRPTPS_69_18

Outlines

Abstract
Copyright

https://doi.org/10.4103/jrptps.JRPTPS_69_18

Comparison of Donepezil and Riluzole in Improving Spatial Memory of Male Wistar Rats

Author(s):

Sina Andalib¹,

Mojtaba Ziaee

^2,*,

Faezeh Mozafari¹,

Reza Hosseini¹,

Mahdieh Anoush³

1Department of Pharmacology, School of Pharmacy, Zanjan University of Medical Sciences, Zanjan, Iran

2Medicinal Plants Research Center, Maragheh University of Medical Sciences, Maragheh, Iran

3Applied Pharmacology Research Center, Zanjan University of Medical Sciences, Zanjan, Iran

Journal of Reports in Pharmaceutical Sciences:Vol. 8, issue 2; 211-6

Published online:Dec 31, 2019

Article type:Research Article

How to Cite:Sina AndalibMojtaba ZiaeeFaezeh MozafariReza HosseiniMahdieh AnoushComparison of Donepezil and Riluzole in Improving Spatial Memory of Male Wistar Rats.J Rep Pharm Sci.8(2):e147381.https://doi.org/10.4103/jrptps.JRPTPS_69_18.

Abstract

Purpose: Alzheimer’s disease (AD) is a degenerative brain disorder and the major cause of dementia and cognitive deficits in the elderly. Riluzole modulates glutamate concentration and improves memory performance in aged rats and may be of benefit in AD. Donepezil is a cholinesterase inhibitor that is used for the treatment of mild-to-moderate AD. In this study, we compared their effects on attenuation of learning and memory deficits in a rat model of AD.
Materials and Methods: Scopolamine injection for 14 consecutive days induced memory impairment. Effect of riluzole on this impaired memory was evaluated by Morris water maze protocols: accusation phase and probe trial test. Adult male Wistar rats (250–300 g) were trained for 4 consecutive days, 24 hours after last scopolamine injection. Spatial memory and learning index (%) were measured depending on the time taken to find the platform and the time utilized in the target quadrant (Q2). The time/distance was measured by the computer. Results were analyzed by one-way analysis of variance and Tukey post hoc.
Results: Riluzole was effective in the treatment of memory impairment of scopolamine-injected group. The riluzole-treated group, on test day, showed better spatial memory rather than scopolamine-treated group. Besides, learning index (%) improvement was significantly higher in the riluzole-treated group, rather than scopolamine-injected group.
Conclusion: It can be concluded that riluzole administration at the same time with scopolamine injection or after it causes marked improvements in learning index during training days and the spatial memory on the test day. Therefore, this study strengthens the hypothesis that acute riluzole treatment is capable of treatment of diseases related to memory impairment such as AD.

Keywords

comments

Crossmark

Checking

Share on

Comments

Number of Comments:0

Cited by

Metrics

Get Permission (article level)

Purchasing Reprints

Copyright Clearance Center (CCC) handles bulk orders for article reprints for Brieflands. To place an order for reprints, please click here ( https://www.copyright.com/landing/reprintsinquiryform/ ). Clicking this link will bring you to a CCC request form where you can provide the details of your order. Once complete, please click the ‘Submit Request’ button and CCC’s Reprints Services team will generate a quote for your review.

Search Relations

Author(s):

Sina Andalib:[PubMed][Scholar]
Mojtaba Ziaee:[PubMed][Scholar]
Faezeh Mozafari:[PubMed][Scholar]
Reza Hosseini:[PubMed][Scholar]
Mahdieh Anoush:[PubMed][Scholar]